Transgenomics has appointed John Thompson as a Class II director of the firm. He will also serve on the audit committee of the company's board of directors. Thompson was previously senior vice president of strategy and corporate development at Invitrogen and was also previously senior vice president of strategy and business development at Dexter.
New York-Presbyterian/Weill Cornell Medical Center has appointed Christopher Cunniff to the director of the division of medical genetics. Previously, Cunniff was chief of medical and molecular genetics at the University of Arizona College of Medicine. He also served as co-medical director of the Children's Clinics for Rehabilitative Services and was recently a professor of pediatrics with joint appointments in pathology, public health, and obstetrics and gynecology at the University of Arizona College of Medicine. He also previously served as secretary of the American College of Medical Genetics and as president of the American Board of Medical Genetics.